[ 11 C]Methionine PET vs . [ 18 F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients.
Motokazu SatoToshihiko SatoChihiro HozumiQinghong HanKohei MizutaSei MorinagaByung Mo KangNoritoshi KobayashiYasushi IchikawaAtsushi NakajimaRobert M HoffmanPublished in: Anticancer research (2024)
MET-PET can out-perform FDG PET for accurate detection of primary and metastatic cancer in the trunk and can determine the extent of methionine addiction of cancer, thereby indicating whether cancer patients can benefit from methionine-restriction therapy.
Keyphrases
- positron emission tomography
- pet ct
- papillary thyroid
- computed tomography
- pet imaging
- squamous cell
- squamous cell carcinoma
- small cell lung cancer
- end stage renal disease
- high resolution
- amino acid
- chronic kidney disease
- ejection fraction
- lymph node metastasis
- type diabetes
- stem cells
- blood pressure
- skeletal muscle
- bone marrow
- young adults
- childhood cancer
- peritoneal dialysis
- blood glucose
- replacement therapy
- glycemic control